Three regenerative medicine commercialization experts to support researchers in entrepreneur-in-residence program
One-year pilot program launched with the help of a grant from Intellectual Property Ontario
Summer by Design draws international regenerative medicine researchers to Toronto for a crash course in commercialization
Program provided an in-depth look at commercializing regenerative medicine and the life sciences ecosystem in Canada
Summer by Design participants from global institutions to learn about regenerative medicine commercialization at U of T
Global and Canadian participants will come together to learn, build networks and explore the Canadian regenerative medicine ecosystem
Twenty-nine Therapeutics and Re:Pair Genomics win first and second place at Medicine by Design’s Building a Biotech Venture Pitch Competition
Pitches focused on treating a difficult form of cancer and enhancing gene therapy treatments take the top spots
Medicine by Design and CCRM announce strategic alliance to bolster Canada’s globally-leading position in regenerative medicine
This alliance is set to unlock Toronto's potential as a globally-leading ecosystem for regenerative medicine
Medicine by Design to be flagship partner in a state-of-the-art training program for next generation regenerative medicine leaders
New program to offer broad training in regenerative medicine including the integration of Medicine by Design's entrepreneurship and commercialization programs.
adMare Bioinnovations and Medicine by Design partner to support translation priorities in the Toronto life sciences ecosystem
Partnership to accelerate health innovation commercialization in the Toronto life sciences ecosystem and in Canada
Medicine by Design announces new strategic plan to advance regenerative medicine and transform healthcare globally
Community collaboration drove the new commitments in bold five-year plan
Medicine by Design symposium panel explores strategies for strengthening Canada’s bioinnovation ecosystem
Themes like lessons learned from COVID-19, symbiotic partnerships and access to risk capital emerge in wide-ranging discussion.
Pivotal Experiment Fund to accelerate Medicine by Design-funded research toward impact
Medicine by Design's $4-million Pivotal Experiment Fund aims to bridge one of the critical gaps in the “valley of death” between a research discovery and a translatable therapy.
Panel of Canadian regenerative medicine leaders tackle translation and commercialization challenges in panel discussion
How do trainees get started on a path toward developing a product or starting a company? What steps do researchers need to take to move their regenerative medicine discoveries from the lab toward clinical impact? These are just some of the questions an expert panel tackled on July 30 at a virtual event titled Translating Research to Impact – Leveraging Our Ecosystem.
Medicine by Design launches Translation Talks
Weekly webinar series for trainees to cover key concepts in translation and commercialization of regenerative medicine.
Summer by Design
How do you move innovative regenerative medicine discoveries out of the lab efficiently and effectively so [...]
Trainees pitch business ideas as part of Medicine by Design communications workshop
The competition was the culmination of Medicine by Design’s “Pitching Science” workshop, a six-week long program for graduate students, post-doctoral fellows and research associates
Medicine by Design and Creative Destruction Lab partner to accelerate the commercialization of world-class research in regenerative medicine
Organizations collaborating to launch a health-themed cohort at CDL-Toronto to help technical teams take their health innovations to market by providing access to accomplished mentors and investors in life sciences.